CD163 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD163 monoclonal antibodies for research focused on understanding this important immune system protein. CD163 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD163 is a scavenger receptor primarily expressed on macrophages and plays a crucial role in the immune response by mediating the clearance of hemoglobin-haptoglobin complexes. CD163 is actively involved in anti-inflammatory processes and has been linked to various diseases, including cancer and chronic inflammatory conditions. Understanding CD163 function is essential for elucidating its potential as a therapeutic target and biomarker in disease progression. Researchers worldwide rely on CD163 monoclonal antibodies to advance their studies in immunology and disease mechanisms. CD163 monoclonal antibodies enable detailed investigation of cellular pathways and molecular interactions in both normal and pathological states. Santa Cruz Biotechnology monoclonal antibodies for CD163 continue to support breakthrough discoveries in immunology research and therapeutic development.